Sim Scott

Today we're proud to announce the launch of the GENEQ Global International Advisory Board (IAB). It is a significant step in achieving our mission to make genomic and precision medicine more accessible, equitable and personalised — regardless of geography or ancestry. At GENEQ Global, we're building a long-term model of genomics implementation that supports governments, healthcare systems, companies and industry, as they design and implement genomic programmes that work for the populations...

Too often, implementation conversations focus on technology alone. But genomic medicine is a systems transformation. It intersects with clinical care, digital infrastructure, finance, regulatory alignment and long-term political commitment. At GENEQ Global, we work with governments, health systems and partners to move from pilot initiatives to sustainable, system-level capability, aligning strategy, communication and delivery, so that precision medicine translates into measurable health impact.